Blog | HemaCare

Encapsulated human stem cell–derived beta cells: Promising treatment for Type I diabetes?

Sep 12, 2016 9:11:02 AM / by Stacy Matthews Branch, DVM, PhD posted in blood glucose, cytotoxic T cells, Dendritic cells, diabetes, stem cells, type 1 diabetes

0 Comments

The challenge to effectively and safely restore proper control of blood glucose (sugar) levels (referred to as glycemic control) in people with diabetes is ongoing. The standard treatment for type 1 diabetes remains to be proper monitoring of blood glucose levels with daily insulin injections. However, patient compliance often limits its effectiveness. Pancreas transplantation is associated with limited donor tissue availability and with side effects due to the immune system suppression needed to reduce the risk of tissue rejection.

Read More

Pacifying NK Cells to Block Type 1 Diabetes

Jul 27, 2015 1:00:46 PM / by Daisy posted in antibody therapeutics, research, streptozotocin, type 1 diabetes

0 Comments

Mice studies show that the use of an antibody towards NK cells could reduce the development of diabetes in susceptible populations.

Read More

Clinical Trial Results for Type 1 Diabetes: Using Stem cells to Halt the Immune Attack

Feb 25, 2015 1:00:03 PM / by Daisy posted in clinical trial, hematopoietic stem cell transplantation, immunomodulation, Stem Cell Therapy, type 1 diabetes

0 Comments

Redistributing immune cells through unpacking and repacking stem cells in the bone marrow shows promise in type 1 diabetes.

Read More

Dendritic Cells in Treatment for Type 1 Diabetes

Jun 11, 2014 1:00:47 PM / by Maria posted in immune system, research, type 1 diabetes

0 Comments

New research demonstrates that delivery of engineered therapeutic dendritic cells that target lymphoid sites of tolerance induction can compensate for failing tolerance in the patient.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts